Sinus Disease in Young Children With Cystic Fibrosis

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Cystic Fibrosis in ChildrenCystic FibrosisChronic Rhinosinusitis (Diagnosis)Olfactory DisorderOlfactory Impairment
Interventions
DRUG

Ivacaftor or elexacaftor/tezacaftor/ivacaftor

HEMT's are prescribed at the discretion of the treating physician and is not dictated by the principal investigator of this study.

Trial Locations (6)

22903

RECRUITING

University of Virginia, Charlottesville

52242

RECRUITING

University of Iowa, Iowa City

66160

RECRUITING

University of Kansas Medical Center, Kansas City

80045

RECRUITING

Children's Hospital Colorado, Aurora

45229-3039

RECRUITING

Cincinnati Children's Hospital Medical Center, Cincinnati

05446

RECRUITING

University of Vermont, Colchester

All Listed Sponsors
collaborator

University of Kansas Medical Center

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

University of Iowa

OTHER

collaborator

University of Virginia

OTHER

collaborator

University of Vermont

OTHER

collaborator

University of North Carolina, Chapel Hill

OTHER

collaborator

Children's Hospital Colorado

OTHER

lead

University of California, Los Angeles

OTHER